Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure.
Recently, sentinel lymph node dissection has been established for early staging of malignant melanoma. We describe an anaphylactic reaction due to patent blue injection in sentinel lymph node procedure, which was proven by positive results in intradermal testing with patent blue 1:100.
Woltsche-Kahr
I
I
Department of Dermatology, University of Graz, Austria.
Komericki
P
P
Kränke
B
B
Brabek
E
E
Horn
M
M
Schuller-Petrovic
S
S
Richtig
E
E
Aberer
W
W
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D001706:Biopsy; D004396:Coloring Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015552:Injections, Intralesional; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000556:secondary*; D012394:Rosaniline Dyes / Q000008:administration & dosage / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000473:pathology*
D004396:Coloring Agents; D012394:Rosaniline Dyes; C008769:sulfan blue